Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung rehab boosts daily activity in advanced sarcoidosis patients

NCT ID NCT02044939

Symptom relief Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a pulmonary rehabilitation program helps people with Stage IV pulmonary sarcoidosis (advanced lung scarring) become more active in their daily lives. 38 adults took part and were followed for one year. The program aimed to improve exercise ability, reduce shortness of breath, and enhance quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

Jul 2012

Finished

Jul 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Stage IV Sarcoidosis * No hospitalization for respiratory distress in the 3 months preceding the inclusion * Dyspnea on exertion * Age over 18 years Exclusion Criteria: * Physical disability does not allow the creation of a rehabilitation program * Inability to give written consent to the study * Refusal of contraception in women of childbearing age * Inability to participate in the entire study * No cover by the social security system * Inability to perform self-questionnaires etude The trial does not include special populations include: * Pregnant women * Breastfeeding women * People in emergencies * Persons unable to consent * Persons deprived of liberty

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stage 4 pulmonary sarcoidosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pulmonary sarcoidosis sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stage 4 pulmonary sarcoidosis

Contacts and locations

Locations

  • CHU Nord, APHM Marseille

    Marseille, 13354, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69310, France

  • Clinique des Maladies Respiratoires, CHRU de LILLE

    Lille, Nord, 59037, France

  • Clinique des Voies Respiratoires, Hôpital Larrey

    Toulouse, 31059, France

  • Hôpital Maison Blanche, CHU de Reims

    Reims, 51100, France

  • Service de Pneumologie, CH Arras

    Arras, 62000, France

  • Service de Pneumologie, CH Béthune

    Béthune, Pas De Calais, 62408, France

  • Service de Pneumologie, Hôpital Pasteur - Pavillon H, CHU de Nice

    Nice, 06002, France

  • Service de Pneumologie, Hôpital Victor Provo

    Roubaix, 59056, France

  • Service de Pneumologie, Hôpital européen Georges Pompidou. AP-HP

    Paris, 75015, France

  • Service de pneumologie, Hôpital Avicenne AP-HP

    Bobigny, 93009, France